EZZ Life Science Holdings Ltd. (AU:EZZ) has released an update.
EZZ Life Science Holdings Ltd., an Australian genomic life science company, announced the issuance of 1,708,200 new shares to a sophisticated investor at $0.50 each, under section 708A(5)(e) of the Corporations Act without the need for disclosure to investors. The company, which focuses on addressing significant health challenges and has a robust e-commerce presence, confirms compliance with the necessary legal provisions and no excluded information was required to be disclosed in this notice.
For further insights into AU:EZZ stock, check out TipRanks’ Stock Analysis page.
